€7.66
2.13%
Xetra, Sep 17, 05:35 pm CEST. Closed.
ISIN
DE0005157101
Symbol
HNL
Index

Dr. Hönle Stock price

€7.66
-0.28 3.53% 1M
-1.64 17.63% 6M
+0.72 10.37% YTD
-1.26 14.13% 1Y
-11.69 60.41% 3Y
-39.49 83.75% 5Y
-16.64 68.47% 10Y
+0.20 2.68% 20Y
Xetra, Closing price Thu, Sep 17 2026
+0.16 2.13%
ISIN
DE0005157101
Symbol
HNL
Index
Sector

Is Dr. Hönle a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,134 stocks worldwide.

Key metrics

Basic
Market capitalization
€45.7m
Enterprise Value
€86.7m
Net debt
€41.0m
Cash
€7.0m
Shares outstanding
6.1m
Valuation (TTM | estimate)
P/E
negative
P/S
0.5 | 0.5
EV/Sales
0.9 | 0.9
EV/FCF
22.5
P/B
0.6
Dividends
DPS
€0.00
Yield 1Y | 5Y
0.0% | 0.2%
Growth 1Y | 5Y
- | -100.0%
Payout 1Y | 3Y
0.0% | 0.0%
Increased
0 Years
Financials (TTM | estimate)
Revenue
€91.8m | €94.5m
EBITDA
€6.1m
EBIT
€474.0k
Net Income
€-3.6m
Free Cash Flow
€3.9m
Growth (TTM | estimate)
Revenue
-6.1% | 0.9%
EBITDA
73.3%
EBIT
104.9%
Net Income
71.6%
Free Cash Flow
108.1%
Margin
Gross
63.5%
EBITDA
6.6%
EBIT
0.5%
Net
-3.9%
Free Cash Flow
4.2%
Financial Health
Equity Ratio
52.8%
Return on Equity
-4.1%
ROCE
0.4%
ROIC
0.7%
Debt/Equity
0.6
More
EPS
€-0.6
FCF per Share
€0.6
Short interest
-
Employees
528
Rev per Employee
€180.0k

Dr. Hönle Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a Dr. Hönle forecast:

6x Buy
86%
1x Hold
14%

Analyst Opinions

7 Analysts have issued a Dr. Hönle forecast:

Buy
86%
Hold
14%

Financial data from Dr. Hönle

Mar '26
+/-
%
92 92
6% 6%
100%
- Direct Costs 34 34
15% 15%
37%
58 58
0% 0%
63%
- Selling and Administrative Expenses 41 41
1% 1%
44%
- Research and Development Expense - -
-
-
6.10 6.10
73% 73%
7%
- Depreciation and Amortization 5.62 5.62
57% 57%
6%
EBIT (Operating Income) EBIT 0.47 0.47
105% 105%
1%
Net Profit -3.60 -3.60
72% 72%
-4%

In millions EUR.

Don't miss a Thing! We will send you all news about Dr. Hönle directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Dr. Hönle AG engages in the development, manufacture, and sale of light-emitting diode ultraviolet (UV) products. It operates through the following segments: Equipment and Systems; Adhesives; and Glass and Lamps. The Equipment and Systems offers UV products that are used for drying inks and coatings, curing adhesives and plastics, disinfecting surfaces, and sunlight simulation. The Adhesive segment includes industrial adhesives for a spectrum of applications. The Glass and Lamp segment comprises quartz glass tubing and rods for the lamp, automotive, semiconductor, and fibre cable industries as well as lamps for water sterilization and drying of coatings and adhesives. The company was founded by Karl Hönle and Günter Schmid in 1976 and is headquartered in Graefelfing, Germany.

Head office Germany
CEO Markus Arendt
Employees 528
Founded 1976
Website www.hoenle.de

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today